Department of Biomedical Sciences and Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; ; Departments of Imaging and Medicine, Cedars-Sinai Medical Center, and Cedars-Sinai Heart Institute, Los Angeles, CA, USA.
Cardiovasc Diagn Ther. 2012 Jun;2(2):85-93. doi: 10.3978/j.issn.2223-3652.2012.04.03.
Epicardial fat, the local visceral fat depot enclosed by the visceral pericardial sac, surrounds the coronary arteries for most of their course, and may contribute to the development of coronary atherosclerosis through local production of inflammatory cytokines. Several studies which measured epicardial fat volume noninvasively have shown a relationship of increased epicardial fat volume with coronary artery disease, with the presence and progression of coronary plaque, major adverse cardiovascular events, myocardial ischemia and atrial fibrillation. Quantitative measurement of epicardial fat volume from noninvasive imaging modalities such as CT and MRI are feasible, and may play a clinical role in cardiovascular risk assessment. The evidence to date warrants larger studies with follow-up to further investigate the role of epicardial fat as an imaging marker with prognostic importance.
心外膜脂肪是被脏层心包囊包裹的局部内脏脂肪库,围绕着冠状动脉的大部分走行,通过局部产生炎性细胞因子可能有助于冠状动脉粥样硬化的发展。几项通过非侵入性方法测量心外膜脂肪量的研究表明,心外膜脂肪量增加与冠状动脉疾病、冠状动脉斑块的存在和进展、主要不良心血管事件、心肌缺血和心房颤动有关。从 CT 和 MRI 等非侵入性成像方式定量测量心外膜脂肪量是可行的,并且可能在心血管风险评估中发挥临床作用。迄今为止的证据支持进行更大规模的研究,并进行随访,以进一步研究心外膜脂肪作为具有预后意义的成像标志物的作用。